Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03983421 · ClinicalTrials.gov registry record
Feasibility of an Early Detection Program for Early Psychosis on a College Campus
A clinical trial, sponsored by University of New Mexico.
- Completed
- Registry status
- 25
- Enrollment target
NCT03983421: Completed study, sponsored by University of New Mexico.
NCT03983421 is a clinical trial that has completed, run by University of New Mexico. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03983421 has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The objective of the proposed study is to determine the feasibility of an Early Detection program that aims to: (i) identify college students at clinical high risk (CHR) of psychosis or with first episode psychosis (FEP), and (ii) efficiently link them to coordinated specialty care (CSC) services for a 2nd stage screen, a clinical assessment, and appropriate treatment. The study will also determine pathways to care and perceived barriers to care among those students enrolled in Coordinated Specialty Care.
Primary Outcome
Duration of Untreated Psychosis determined upon enrollment to coordinated specialty care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2022-12-31 |
What the finished NCT03983421 record still lists
NCT03983421 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03983421 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03983421 about?
NCT03983421 is a clinical study titled "Feasibility of an Early Detection Program for Early Psychosis on a College Campus". The objective of the proposed study is to determine the feasibility of an Early Detection program that aims to: (i) identify college students at clinical high risk (CHR) of psychosis or with first episode psychosis (FEP), and (ii) efficiently link them to coordinated specialty care (CSC) services fo...
What is the current status of trial NCT03983421?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2019-10-01. Estimated completion is 2022-12-31.
Who is sponsoring clinical trial NCT03983421?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI